Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations
- 15 March 2011
- journal article
- Published by Elsevier BV in Journal of Neuroscience Methods
- Vol. 196 (1), 51-59
- https://doi.org/10.1016/j.jneumeth.2010.12.025
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Proposed mechanism for lipoprotein remodelling in the brainBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Amyloid load in nondemented brains correlates with APOE e4Neuroscience Letters, 2010
- Size-dependent neurotoxicity of β-amyloid oligomersArchives of Biochemistry and Biophysics, 2010
- Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s diseaseActa Neuropathologica, 2010
- Accumulation of intraneuronal Aβ correlates with ApoE4 genotypeActa Neuropathologica, 2010
- GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with α-synucleinNeuroscience Letters, 2009
- Reelin signaling antagonizes β-amyloid at the synapseProceedings of the National Academy of Sciences, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer diseaseJCI Insight, 2008
- Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1Neuron, 2007